FIELD: medicine.
SUBSTANCE: method involves the intramuscular introduction of the preparations Galavite 200 mcg/mouse and Lidocaine 8 mcg/kg of body weight once a day for three days running every 24 hours to experimental animals CBA line mice suffering a burning injury with underlying mycotic and bacterial infections accompanied by anti-infectious protection suppression.
EFFECT: invention enables creating a model of hospital strain formation which is applicable for studying the variations of the properties of opportunistic microorganisms to increasing virulence and antibiotic resistance.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTING INTI-INFECTIOUS BODY RESISTANCE IN CASE OF PURULENT-INFLAMMATORY PROCESSES OF CANDIDA-BACTERIAL ETIOLOGY AT THE BACKGROUND OF EXPERIMENTAL BURN TRAUMA | 2005 |
|
RU2304969C2 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
AGENT FOR TREATING INFLAMMATORY ORAL DISEASES AND METHOD OF TREATING INFLAMMATORY ORAL DISEASES | 2011 |
|
RU2470640C1 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
METHOD FOR COMPLEX ANTIBACTERIAL TREATMENT OF GENERALIZED INFECTION IN SEVERELY BURNED PATIENTS | 2005 |
|
RU2302859C2 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
METHOD FOR ESTIMATING EFFICIENCY OF INFECTIOUS DISEASE THERAPY | 2015 |
|
RU2615417C1 |
PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
METHOD FOR SIMULATING BACTERIAL INFECTION WITH UNDERLYING BURN INJURY | 2013 |
|
RU2530564C1 |
METHOD FOR SIMULATING TYPHOID ON SMALL LABORATORY ANIMALS WITH ARTIFICIAL IMMUNOSUPPRESSION | 2019 |
|
RU2716753C1 |
Authors
Dates
2012-08-10—Published
2010-11-08—Filed